| 200794-250MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C59H85O10P |
|
|
|
| 200794-100MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C59H85O10P |
|
|
|
| 200770-250MG |
|
NA |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C59H85O10P |
|
|
|
| 200770-100MG |
|
NA |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(3,5-diisopropyl-4-methoxyphenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C59H85O10P |
|
|
|
| 200793-250MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C47H61O6P |
|
|
|
| 200793-100MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C47H61O6P |
|
|
|
| 200769-250MG |
|
NA |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
250MG |
C47H61O6P |
|
|
|
| 200769-100MG |
|
NA |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetrakis(4-(tert-butyl)phenyl)-6-oxide-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine
≥95%,99%e.e.
|
100MG |
C47H61O6P |
|
|
|
| 200792-250MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetra-2-naphthalenyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin
≥95%,99%e.e.
|
250MG |
C47H37O6P |
|
|
|
| 200792-100MG |
|
NA |
(3aS,8aS)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetra-2-naphthalenyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin
≥95%,99%e.e.
|
100MG |
C47H37O6P |
|
|
|
| 200768-250MG |
|
952649-50-2 |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetra-2-naphthalenyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin
≥95%,99%e.e.
|
250MG |
C47H37O6P |
|
|
|
| 200768-100MG |
|
952649-50-2 |
(3aR,8aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4,4,8,8-tetra-2-naphthalenyl-6-oxide-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin
≥95%,99%e.e.
|
100MG |
C47H37O6P |
|
|
|
| 200754-1G |
|
NA |
(5aS,10bR)- 2-Mesityl-8-bromo -5a,10b- ?dihydro-4H,?6H-?indeno[2,?1- ?b]?[1,?2,?4]?triazolo[4,?3- ?d][1,?4]?oxazinium Tetrafluoroborate
≥95%,99%e.e.
|
1G |
C21H21N3OBr·BF4 |
|
|
|
| 200753-100MG |
|
NA |
(5aR,10bS)- 2-Mesityl-8-bromo -5a,10b- ?dihydro-4H,?6H-?indeno[2,?1- ?b]?[1,?2,?4]?triazolo[4,?3- ?d][1,?4]?oxazinium Tetrafluoroborate
≥95%,99%e.e.
|
100MG |
C21H21N3OBr·BF4 |
|
|
|
| 200752-100MG |
|
NA |
(5aS,10bR)-2-Mesityl-8-nitro-5a,10b- dihydro-4H,6H-indeno[2,1- b][1,2,4]triazolo[4,3- d][1,4]oxazinium Tetrafluoroborate
≥95%,99%e.e.
|
100MG |
C21H21N4O3·BF4 |
|
|
|
| 200751-100MG |
|
NA |
(5aR,10bS)-2-Mesityl-8-nitro-5a,10b- dihydro-4H,6H-indeno[2,1- b][1,2,4]triazolo[4,3- d][1,4]oxazinium Tetrafluoroborate
≥95%,99%e.e.
|
100MG |
C21H21N4O3·BF4 |
|
|
|
| 200750-100MG |
|
NA |
(5aS,10bR)- 2-Mesityl-8-isopropyl-5a,10b- ?dihydro-4H,?6H-?indeno[2,?1- ?b]?[1,?2,?4]?triazolo[4,?3- ?d][1,4]oxazinium Tetrafluoroborate
≥95%,99%e.e.
|
100MG |
C24H28N3O·BF4 |
|
|
|
| 200749-100MG |
|
NA |
(5aR10bS)- 2-Mesityl-8-isopropyl-5a,10b- ?dihydro-4H,?6H-?indeno[2,?1- ?b]?[1,?2,?4]?triazolo[4,?3- ?d][1,4]oxazinium Tetrafluoroborate
≥95%,99%e.e.
|
100MG |
C24H28N3O·BF4 |
|
|
|
| 200746-100MG |
|
NA |
(5aS,10bR)-2-(Naphthalen-1-yl)-5a,10b- dihydro-4H,6H-indeno[2,1- b][1,2,4]triazolo[4,3- d][1,4]oxazinium Tetrafluoroborate
≥95%,99%e.e.
|
100MG |
C22H18N3O·BF4 |
|
|
|
| 200745-100MG |
|
NA |
(5aR,10bS)-2-(Naphthalen-1-yl)-5a,10b- dihydro-4H,6H-indeno[2,1- b][1,2,4]triazolo[4,3- d][1,4]oxazinium Tetrafluoroborate
≥95%,99%e.e.
|
100MG |
C22H18N3O·BF4 |
|
|
|
